Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of misleading statements and improper business practices that have led to significant financial losses for investors during the specified class period [3][4][5]. Group 1: Allegations and Lawsuit Details - The class action lawsuit claims that Zynex shipped medical products in quantities exceeding patient needs, resulting in inflated revenue figures [3]. - The lawsuit highlights that Zynex's practices attracted scrutiny from insurers, including Tricare, which could lead to negative consequences such as exclusion from insurer networks and potential penalties from federal agencies [3]. - A report published by STAT accused Zynex of operating an "oversupplying scheme," sending excessive quantities of supplies to bill insurers unjustifiably, which contributed to a decline in Zynex's stock price by over 5% following its release [4]. Group 2: Financial Impact - On March 11, 2025, Zynex announced a revenue shortfall for Q4 and full year 2024, attributing it to slower payments from certain payers, which included a temporary suspension of payments from Tricare pending a review of previous claims [5]. - Following the announcement of the revenue shortfall, Zynex's stock price plummeted by more than 51% [5].